Target intelligence / Profile preview

Foot-and-mouth disease virus capsid protein (FMDV capsid protein) (FMDV capsid protein)

Target
FMDV capsid protein
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The Foot-and-mouth disease virus (FMDV) capsid protein is a complex structural assembly composed of four distinct polypeptides: VP1, VP2, VP3, and VP4, which together form a pseudo-T=3 icosahedral shell (UniProt: P03305). This capsid serves the dual purpose of protecting the viral RNA genome from environmental degradation and facilitating the infection of host cells by recognizing specific cell surface receptors (PMID: 28634238). The primary mechanism of entry involves the binding of a highly conserved Arg-Gly-Asp (RGD) motif, located within the flexible G-H loop of the VP1 protein, to host cell integrins such as αvβ6 (PMID: 15731258). As the most exposed component of the virion, the capsid is the principal target for the host's immune system and the primary focus of vaccine development, including traditional chemically inactivated vaccines and modern virus-like particles (PMID: 31405115). However, the high mutation rate of the FMDV genome leads to significant antigenic variation across seven major serotypes, which complicates the development of universal therapeutics (PMID: 25100862). Current drug discovery efforts target the capsid to develop entry inhibitors or stabilizers that prevent the pH-dependent uncoating of the virus within host endosomes. These structural proteins are also utilized as diagnostic markers to distinguish between infected and vaccinated animals in disease surveillance programs.

Other names
FMDV structural proteinVP1VP2VP3VP4P1 polyproteinFMDV coat protein
02

Mechanism of action

Neutralization of viral particles and inhibition of host cell entry by blocking receptor binding sites or inducing protective immune responses.

03

Biological functions

Viral entryReceptor bindingGenome packagingHost cell attachmentViral uncoating
04

Disease associations

InfectionFoot-and-mouth disease
05

Safety considerations

Antigenic variation across serotypesCapsid instabilityRisk of incomplete virus inactivationShort duration of vaccine-induced immunity
06

Interacting drugs

Inactivated Foot-and-mouth disease virus vaccine

4 more in the full profile.

07

Biomarkers

Anti-FMDV structural protein antibodiesFMDV antigenViral RNA load

Beyond the preview

Go deeper on Foot-and-mouth disease virus capsid protein (FMDV capsid protein) (FMDV capsid protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-mouth disease virus capsid protein (FMDV capsid protein) (FMDV capsid protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call